Skip to main content
Science
Clinical Trials
Guide to Clinical Trials
Clinical Trials in Children
Data and Results
Integrity and Transparency
Diversity
Plain Language Study Results
Expanded Access & Compassionate Use
Find a Trial
Areas of Focus
Rare Disease
Internal Medicine
Inflammation & Immunology
Vaccines
Oncology
Anti Infectives
Areas of Innovation
Medicinal Sciences
Precision Medicine
Maternal Immunization
mRNA Technology
Diseases & Conditions
Coronavirus Resources
Product Pipeline
Research Sites
Products
How Drugs are Made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Global Supply
Manufacturing Sites
Medicine Safety
Health Literacy
Treatment Choices
Partnering With Patients
Tips for Patients
Reporting Adverse Events
Counterfeiting
Product Safety
Product List
Product Contacts
PfizerPro for Professionals
Patient Assistance Programs
Distributors
Pfizer Distributors
Stories
Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Newsroom
Press Releases
Media Asset Library
Updates and Statements
Partnering News
Media Contacts
About
People
Executives
Board Members
Scientists
Patient Stories
Colleague Stories
Responsibility
Ethics & Compliance
Responsible Business
Patient Advocacy & Engagement
Global Impact
Diversity, Equity, and Inclusion
Environmental Sustainability
Human Rights
Health & Safety
Intellectual Property
EHS Governance
Misinformation
Programs & Policies
Grants
Political Partnership
Working with Healthcare Professionals
Prescription Value & Pricing
Privacy Principles
Ready for Cures
Transparency in Grants
Policy Positions
Corporate Governance
Corporate Governance Overview
Board Committees & Charters
The Pfizer Board Policies
Corporate Governance FAQs
Contact Our Directors
Purpose
History
Careers
Partners
Research and Business Development Partnerships
Venture Investments
Business to Business
Pfizer CentreOne
Pfizer Ignite
Submit Your Opportunities
Contact Us
Careers
Investors
Search
Contact Us
Hamburger
Changed
Changed
How can we help you?
0
search results for
Suggestions within Pfizer.com
Header close
Header close
Home
Newsroom
Press Releases
Press Releases
Filter Options
Archive Date
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Month
January
February
March
April
May
June
July
August
September
October
November
December
View 12
View 12
View 24
View 48
Categories
Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines
Keywords
All Keywords
Careers
Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines
August 2022
08.05.2022
Prescription Medicines
Medicines
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
June 2022
06.30.2022
Prescription Medicines
Medicines
Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™
06.14.2022
Prescription Medicines
Medicines
Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA
06.04.2022
Prescription Medicines
Medicines
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer
Page
1
Page
2
Page
3
Current page
4
Cookies Preference
